Cytel

On Rare Disease Day, we recognize the millions of individuals and families affected by rare conditions—and the power of collaboration in driving progress. A heartfelt thank you to our employees, partners, and sponsors for your dedication to advancing research, innovation, and data-driven solutions that bring hope to those who need it most. Together, we are accelerating change, breaking barriers, and shaping a future where every rare disease patient has access to better treatments and brighter possibilities. Discover how Cytel supports rare disease research: https://lnkd.in/eTPMA5j2 #RareDiseaseDay #MakingADifference #Collaboration #ThankYou #Cytel

As clinical trials become more complex, data sources multiply, and real-world evidence (RWE) gains prominence, the role of the statistician is evolving into clinical data scientists — hybrid professionals who combine technical expertise with strategic leadership to drive advancements in drug development. Join Dr. Alexander Schacht ( The Effective Statistician Podcast), Yannis Jemiai, Benjamin Piske and Flaminia Chiesa for an insightful webinar on how statisticians are leading innovation in today’s rapidly evolving clinical landscape. Register here: https://hubs.ly/Q038L-Gq0

As we move into the implementation phase of the new #EUHTAR, it becomes crucial to map out the method requirements for #EUJCA and local #HTA methods guides. Congratulations to our various colleagues for your close collaboration across teams and partners to make this publication a success! This publication focuses on mapping these requirements and pinpointing the challenges of #dataanalytics harmonization. This analysis is vital as companies gear up for EU JCA #evidence packages and submissions, which could have implications for local #EU #marketaccess strategies. Read the full publication on Becaris Publishing Limited: https://lnkd.in/eGEzAdDB A special #kudos to all involved! Grammati Sarri Lydia Vinals, PhD Lilia Leisle, PhD Ingrid CLAVERIE-CHAU David Smalbrugge Dr. Kai Lucaßen Yannis Jemiai co.faktor GmbH - A Cytel Company steve consultants #EUJCA #EUHTAR #HTA #data #evidencesynthesis

AI-powered innovations are sweeping across the life sciences industry. Haripria Ramesh Babu, Boaz Adler, and Valeria Mazzanti discuss Cytel’s newly launched #AI-powered #R coding assistant within the East Horizon platform, which enables #biostatisticians to generate complex R code instantly; customize trial simulations with precise #statistical methods; and reduce manual #coding errors and speed up model validation. Read the post to learn more: https://hubs.ly/Q038xfdC0

🌟 Don't miss tomorrow's webinar! PBPK is revolutionizing #drug development by offering a deeper understanding of how drugs behave within the human body. David Dahlgren discusses how #PBPK enables more informed decisions, minimizes costly failures, and helps bring safe, effective treatments to patients faster. Read the post and register for the webinar: https://hubs.ly/Q038kvpn0

The #Biometrics #FSP outsourcing market is evolving faster than ever. Corey Dunham discusses #opensource, #AI, global reach, and cost efficiency, and the impact on 2025 and beyond. Read the post: https://hubs.ly/Q038dyq60 #biotech #pharma #pharmaceutical #drugdevelopment #clinicaldevelopment #software #artificialintelligence #data #programming #R

We are pleased to announce that Cytel will be represented by our experts Grammati Sarri, David Smalbrugge and Lilia Leisle, PhD at the upcoming World EPA Congress in Amsterdam on March 5-6. As leaders in Evidence, Value and EUJCA, our team is dedicated to delivering innovative data and access solutions for our clients in the pharmaceutical industry. Please feel free to reach out to our experts to arrange a meeting Reach out to us: https://lnkd.in/eic65R6k #WorldEPACongress #PharmaLeadership #Cytel #Evidence #Pricing #EUJCA #EUHTAR #HTA

Ready for Adaptive Designs and Multiple Testing Procedures Workshop in Regensburg? Meet up with our colleagues Boaz Adler, Valeria Mazzanti, Pantelis Vlachos, Laurent Spiess & Alena Shubina to discover how we empower life science leaders to realize the full potential of their therapies🎇 Don't forget to join in at our various presentations as well! Discover more: https://lnkd.in/eURFPR4Z #AdaptiveTrialDesigns

🧪📊Physiologically-Based Pharmacokinetics (PBPK) modeling and simulation is a powerful tool that enhances early-stage clinical development by providing reliable human pharmacokinetic predictions. 🎯 From candidate selection to investigational medicinal product (IMP) manufacturing, PBPK modeling helps streamline decision-making, optimize resource allocation, and reduce development risks. In this webinar our experts explore the fundamentals of PBPK modeling and how it can be applied to guide, de-risk, and accelerate drug development. Register here: https://hubs.ly/Q037JVmb0 #PBPK #Modeling #Simulation

Launching a #pharmaceutical product requires meticulous planning, strategic storytelling, and continuous engagement. Philipp Bauknecht shares how to prepare effective communication materials from Phase 1 pre-launch preparation to Phase 3 post-launch expansion to help ensure a successful launch and a strong #market presence. Read the post: https://hubs.ly/Q037xjcg0 #pharma #biotech #regulatoryaffairs #EMA #healthcare #clinicaltrials #clinicaldevelopment #drugdevelopment #Phase1 #Phase2 #Phase3